NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.
about
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Profile of minocycline and its potential in the treatment of schizophreniaEarly mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected miceImpaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity.In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.The effects of ketamine and risperidone on eye movement control in healthy volunteers.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsNMDA Receptors Regulate the Structural Plasticity of Spines and Axonal Boutons in Hippocampal Interneurons.Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Ketamine and phencyclidine: the good, the bad and the unexpected.Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learningSTEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorderProlonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex.Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophreniaKetamine alters the neurogenesis of rat cortical neural stem progenitor cells.Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeysImpaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.Schizophrenia as a disorder of communication.Influence of pharmacological manipulations of NMDA and cholinergic receptors on working versus reference memory in a dual component odor span taskChronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in ratsChronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivoAdjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trialsSleep and plasticity in schizophrenia.Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway.Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in miceGlutamatergic transmission in schizophrenia: from basic research to clinical practiceNMDA Receptor Activity in Neuropsychiatric Disorders.Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.N-Methyl-D-Aspartate Receptor (NMDAR)-Driven Calcium Influx Potentiates the Adverse Effects of Myocardial Ischemia-Reperfusion Injury Ex Vivo.Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment.Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease.Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation.MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats.Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus.Altered intrinsic and extrinsic connectivity in schizophrenia.
P2860
Q26830533-5432020D-DC15-4CFF-9AFD-05272C2A63C7Q26864400-E676283A-5F60-4F7A-B1BF-373383B7938BQ27340506-29ADB01B-FC65-4A6F-B3D8-574E0CD1DD92Q30384905-DCAFC916-A000-4216-8D79-A31D33FDBA56Q30413276-2BBB2872-3D6D-4F63-B244-0CD1B8937EC2Q30419647-F243857D-9109-4069-91F4-CA3D519D7A68Q30437913-F9772F09-270A-4F26-8C88-3B91B68B472FQ33718794-B4EE12D7-2862-4557-B3B3-2535A2FD5EADQ33785739-14F3F247-DFEB-449A-8C11-1BA2C8891E43Q34306261-C17A451A-49E5-47BF-8FED-7AD0DEDEDB26Q34405264-FDBF2CF5-A59F-4132-B4C2-D3BE41DFCFCBQ34480719-D9A01651-6894-4485-AB4D-A1912C75226AQ34515185-49640480-1B82-48CF-B03C-9A25DADB3AC3Q35191367-6C7FB4DD-5A72-4EB7-8A30-04FC67E96AA5Q35718134-E12C919A-67C4-4A87-BDC9-CA5BE37DED23Q36174107-4EC7DEA5-03F4-42B9-93D9-B41C19E42C1DQ36426434-E86773A4-60F8-46E3-B6F3-E9AA79247FE3Q36578017-A6B6BC71-320B-41C4-8D93-4DCD8C128194Q36604589-5DBD476E-887A-4091-8C8D-D9133EC33E29Q36798980-EC75A96E-5881-4335-B9AE-7D1A35F265B1Q36882950-F95F47C3-3898-4B6B-8314-1357E35763DEQ36935472-DB236AED-675E-4126-BABD-9D931731D1D3Q37111054-8F715F0E-A25E-4C34-ACE7-B30D639FAFEAQ37177032-F11DA905-2651-44A0-94B4-B030DB74E72BQ37228346-4FA16CE5-2E87-4ECA-BD03-33415280D8BCQ37426505-58732AEF-7016-4ADB-8970-81CCE119E1D2Q37663266-D4F6F047-2563-4E82-AE84-B3821AC7C188Q37686822-A4F9AEC6-97BB-4B97-B543-1CAADC3F7DFAQ37980657-1000EFD4-5B12-4D42-A2D8-F8CBBA93C547Q38114881-243D1C04-A1E0-416F-B26D-E081EF1698C0Q38149953-828C5B6F-0993-4E8C-BB82-4F5D671D785FQ38641093-0AE52FBA-2DBD-401C-A5AC-FF9F78874B55Q38965146-6885649E-F53B-4231-8B8E-82250180348EQ39121207-C92097B2-CE57-472C-B1AE-51AD356EF30FQ40251062-B02A87B7-29C8-4A9F-BCCE-95715F91A8C2Q40726881-83958F89-1025-4FAA-9880-1005A3B8DE4AQ41028473-562DBE2D-5F51-4EDA-9B24-E0AD9D33BEBAQ43011663-AD9C6DBB-54C5-466E-B9BC-01F1896EFF6DQ44179800-081FBAC9-D9D3-4D82-9640-8299B50DB6C6Q47118295-6631ECDB-2EED-42E1-94E6-F1D3DCEB9C2D
P2860
NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@en
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@nl
type
label
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@en
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@nl
prefLabel
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@en
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@nl
P2093
P1433
P1476
NMDA receptors, cognition and ...... eptor hypofunction hypothesis.
@en
P2093
Francois Gastambide
Gary Gilmour
John Talpos
Laetitia Fellini
Mark Tricklebank
Niels Plath
Sophie Dix
Thomas Steckler
P304
P356
10.1016/J.NEUROPHARM.2011.03.015
P577
2011-03-21T00:00:00Z